MUCOCUTANEOUS DISORDER

MUCOCUTANEOUS DISORDER was reported 159 times

MUCOCUTANEOUS DISORDER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Type I Interferon Receptor Antagonist [EPC] 1 0.0005
1 Macrolide Antimicrobial [EPC] 18 0.0003
2 Antihypoglycemic Agent [EPC] 1 0.0002
3 Paramagnetic Contrast Agent [EPC] 1 0.0002
4 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 1 0.0002
5 Epidermal Growth Factor Receptor Antagonist [EPC] 7 0.0001
6 Programmed Death Receptor-1 Blocking Antibody [EPC] 14 0.0001
7 Antimalarial [EPC] 1 0.0001
8 Antiprotozoal [EPC] 1 0.0001
9 B Lymphocyte Stimulator-specific Inhibitor [EPC] 3 0.0001
10 Nonergot Dopamine Agonist [EPC] 1 0.0001
11 CTLA-4-directed Blocking Antibody [EPC] 3 0.0001
12 Cholinesterase Inhibitor [EPC] 1 0.0001
13 Microtubule Inhibitor [EPC] 8 0.0000
14 Recombinant Human Growth Hormone [EPC] 1 0.0000
15 Hemoglobin S Polymerization Inhibitor [EPC] 1 0.0000
16 Nucleoside Metabolic Inhibitor [EPC] 12 0.0000
17 Bile Acid [EPC] 1 0.0000
18 Progesterone [EPC] 1 0.0000
19 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
20 Platinum-based Drug [EPC] 11 0.0000
21 HER2/neu Receptor Antagonist [EPC] 3 0.0000
22 Aldosterone Antagonist [EPC] 5 0.0000
23 Rifamycin Antibacterial [EPC] 1 0.0000
24 Interleukin-17A Antagonist [EPC] 1 0.0000
25 Folate Analog Metabolic Inhibitor [EPC] 11 0.0000
26 Nonsteroidal Anti-inflammatory Drug [EPC] 31 0.0000
27 Calcineurin Inhibitor Immunosuppressant [EPC] 3 0.0000
28 Serotonin-3 Receptor Antagonist [EPC] 3 0.0000
29 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
30 Purine Antimetabolite [EPC] 2 0.0000
31 Kinase Inhibitor [EPC] 11 0.0000
32 Janus Kinase Inhibitor [EPC] 3 0.0000
33 Opioid Agonist [EPC] 5 0.0000
34 Mood Stabilizer [EPC] 4 0.0000
35 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
36 Vascular Endothelial Growth Factor Inhibitor [EPC] 3 0.0000
37 BCL-2 Inhibitor [EPC] 1 0.0000
38 CD20-directed Cytolytic Antibody [EPC] 5 0.0000
39 Antidote [EPC] 1 0.0000
40 alpha-Adrenergic Blocker [EPC] 2 0.0000
41 Leukocyte Growth Factor [EPC] 2 0.0000
42 Anti-epileptic Agent [EPC] 3 0.0000
43 Vitamin D [EPC] 4 0.0000
44 Vitamin B12 [EPC] 4 0.0000
45 Alkylating Drug [EPC] 3 0.0000
46 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
47 RANK Ligand Inhibitor [EPC] 2 0.0000
48 Interleukin-12 Antagonist [EPC] 1 0.0000
49 Vitamin C [EPC] 4 0.0000
50 Interleukin-23 Antagonist [EPC] 1 0.0000
51 Corticosteroid [EPC] 12 0.0000
52 Parathyroid Hormone Analog [EPC] 1 0.0000
53 Retinoid [EPC] 2 0.0000
54 Fluoroquinolone Antibacterial [EPC] 1 0.0000
55 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
56 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
57 Platelet Aggregation Inhibitor [EPC] 3 0.0000
58 Atypical Antipsychotic [EPC] 2 0.0000
59 Tumor Necrosis Factor Blocker [EPC] 4 0.0000
60 Proton Pump Inhibitor [EPC] 2 0.0000
61 beta-Adrenergic Blocker [EPC] 1 0.0000
62 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000